95.80
-3(-3.04%)
Currency In HKD
Sector
Healthcare
Industry
Biotechnology
Employees
9595
First IPO Date
December 10, 2021
| Name | Title | Pay | Year Born |
| Dr. Hao Hong Ph.D. | Founder, Chairman & Chief Executive Officer | 0 | 1956 |
| Ms. Rui Yang | Co-Chief Executive Officer & Executive Director | 0 | 1977 |
| Mr. Da Zhang | Chief Financial Officer, Chief Operating Officer, Senior Vice President & Executive Director | 0 | 1981 |
| Dr. Xinhui Hu Ph.D. | Chief Technology Officer & Chief Commercial Officer | 0 | 1973 |
| Mr. Xiangke Xu | Senior Vice President & Company Secretary | 0 | 1979 |
| Ms. Elut Hsu | President & GM | 0 | N/A |
| Dr. Liang Hong | Senior Vice President of Process Development & Application and Executive Director | 0 | 1974 |
| Mr. Chaoyong Chen | Senior Vice President of Resource & Development | 0 | 1982 |
| Mr. Jiang Yingwei | Senior Vice President of Human Resources | 0 | 1977 |
| Dr. Yan Zhou | Senior Vice President | 0 | 1979 |
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.